High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience
{{output}}
Introduction: This multicenter review evaluated the efficacy and safety of osimertinib dose escalation for central nervous system (CNS) progression developing on osimertinib 80 mg in EGFR-mutant NSCLC. ... ...
